SCHEMBL14838413

SCHEMBL14838413

C=Cc1ccc(-c2cc(C3=C(c4cc(-c5cccs5)sc4-c4cccs4)C(F)(F)C(F)(F)C3(F)F)c(-c3cccs3)s2)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.41
EGFR P00533 1/20 0.37
RET P07949 1/20 0.37
KDR P35968 1/20 0.37
CTRC Q99895 1/20 0.37
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ALOX12 P18054 1/20 0.35
CASP1 P29466 1/20 0.35
PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16021800 0.88 DPP4 (0.39) DPP4EGFRRETKDRCTRC
SCHEMBL16021756 0.87 DPP4 (0.55) DPP4EGFRRETKDRCTRC
SCHEMBL915494 0.86 MEN1 (0.34) DPP4KDM4EALDH1A1MEN1GLA
SCHEMBL17616998 0.84 DPP4 (0.37) DPP4EGFRRETKDRCTRC
SCHEMBL14838338 0.83 DPP4 (0.36) DPP4EGFRRETKDRCTRC
SCHEMBL14838253 0.82 HDAC1 (0.33) DPP4KDM4EALDH1A1MEN1GLA
SCHEMBL14838249 0.81 HDAC1 (0.31) DPP4LTA4H
SCHEMBL21291339 0.80 DPP4 (0.49) DPP4EGFRRETKDRCTRC
SCHEMBL14838370 0.79 DPP4 (0.32) DPP4KDM4EALDH1A1GLAGAA
SCHEMBL14838420 0.79 DPP4 (0.35) DPP4KDM4EALDH1A1MEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10556912-B2 Diarylethene compounds and uses thereof SWITCH MATERIALS, INC. (CA) 2020-02-11 US disclosed
US-9227986-B2 Diarylethene compounds and uses thereof SWITCH MATERIALS, INC. (CA) 2016-01-05 US disclosed
US-9227986-B2 Diarylethene compounds and uses thereof SWITCH MATERIALS, INC. (CA) 2016-01-05 US disclosed
US-20140256936-A1 DIARYLETHENE COMPOUNDS AND USES THEREOF SWITCH MATERIALS, INC. (CA) 2014-09-11 US disclosed
US-20140256936-A1 DIARYLETHENE COMPOUNDS AND USES THEREOF SWITCH MATERIALS, INC. (CA) 2014-09-11 US disclosed
WO-2013044371-A1 PHOTOCHROMIC AND ELECTROCHROMIC DIARYLCYCLOPENTENE DERIVATIVES AS OPTICAL FILTERS SWITCH MATERIALS, INC. (CA) 2013-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10556912-B2 Diarylethene compounds and uses thereof KCNH2, KCNH3, SCN2B DPP4 4383/4885EGFR 1177/4885RET 2230/4885
US-20140256936-A1 DIARYLETHENE COMPOUNDS AND USES THEREOF KCNH2, KCNH3, SCN2B DPP4 4383/4885EGFR 1177/4885RET 2230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.